Literature DB >> 14530103

Role of ERCP in the management of predicted mild acute biliary pancreatitis.

Yuk-Pang Yeung1, Siu-Fai Lo, Andrew Wai-Chun Yip.   

Abstract

OBJECTIVE: The role of endoscopic retrograde cholangiopancreatography (ERCP) in mild acute biliary pancreatitis is controversial. This study examined the results of ERCP in patients with predicted mild disease and analysed biochemical and imaging findings in relation to the occurrence of choledocholithiasis. PATIENTS AND METHODS: There were 172 consecutive patients, admitted between January 1998 and December 2000, with the diagnosis of acute pancreatitis. All patients were investigated using transcutaneous ultrasonography and ERCP if biliary aetiology was suspected. Serum bilirubin and alkaline phosphatase were measured, together with abdominal ultrasonographic findings, as potential predictors for choledocholithiasis.
RESULTS: Biliary calculus was the aetiology in 62.8% of patients (108/172). Among these 108 patients, 79.6% (86/108) suffered from mild disease. There were only 80 patients who underwent ERCP, and the incidence of choledocholithiasis was 45% (36/80). Although significant correlation was shown between all three measured parameters (bilirubin, alkaline phosphatase and ultrasonographic abnormalities) and choledocholithiasis, their individual sensitivities, specificities and predictive values were low. Nonetheless, if all three tests were normal, the incidence of ductal stones was significantly lower than that in cases with abnormalities in any one of these parameters (4.8% vs 59.3%).
CONCLUSION: Routine ERCP is not recommended for patients with mild, acute biliary pancreatitis when there is no biochemical derangement or ultrasonographic evidence of a dilated biliary system.

Entities:  

Mesh:

Year:  2003        PMID: 14530103     DOI: 10.1016/S1015-9584(09)60302-X

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  1 in total

1.  Mild acute biliary pancreatitis vs cholelithiasis: are there differences in the rate of choledocholithiasis?

Authors:  Rosa Bertolín-Bernades; Luis Sabater-Ortí; Julio Calvete-Chornet; Bruno Camps-Vilata; Norberto Cassinello-Fernández; Miguel Oviedo-Bravo; Purificación Ivorra-García Monco; Raúl Cánovas-de Lucas; Salvador Lledó-Matoses
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.